Discussing Potentials and Implications of AI-Driven Biomarkers in Oncology Clinical Care at ESMO Asia 2025 - Herbert Loong
@herbloongmd.bsky.social
@myesmo.bsky.social
oncodaily.com/voices/herbe...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMOAsia25 #ESMOAsia2025
Inside ESMO Asia 2025 with Angela Lamarca
@myesmo.bsky.social
oncodaily.com/voices/esmo-...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMOAsia #ESMOAsia25 #ESMOAsia2025
Inside ESMO Asia 2025 with David Planchard
@myesmo.bsky.social
oncodaily.com/voices/esmo-...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMOAsia #ESMOAsia25 #ESMOAsia2025
Inside ESMO Asia 2025 with Deborah Mukherji
@dmukherji.bsky.social
@myesmo.bsky.social
oncodaily.com/voices/esmo-...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMOAsia #ESMOAsia25 #ESMOAsia2025
#ESMOAsia2025 is a great opportunity for Max team members to reconnect with partners and meet physicians from across the region including:
🧡Raj Bhaskar and Aries Teo from our partner organization Takeda
🧡Partner physicians: Dr. Aina Anota from Papua New Guinea and Dr. Prabhat Pradhan from Bhutan